Good MorningEquity markets held steady on Wednesday after signs of economic resilience were offset by signs of weakness. The good news included earnings reports from Target and TJX Companies, which were better than expected and included improved guidance. The bad news included a revision to labor data that wiped out gains made this year.
Minutes from the last FOMC meeting helped support the market on Wednesday. The minutes indicate a high likelihood for an interest rate cut next month and easing economic headwinds for business and consumers.” Featured: 5 Stocks Poised to Soar Under Trump's Presidency (Ad) 
|
Markets | |
As the quarter winds down, investors can look at 13-F filings to determine what the best minds on Wall Street are planning for the coming months. The Securities and Exchange Commission (SEC) requires these filings whenever an individual investor or fund holds a significant enough stake in any give... Read the Full Story |
|
From Our PartnersREVEALED: $194 Trillion Trump Market Pattern
Trump fires off a tweet and stocks tank…
He gives a speech and the markets soar…
Now, a new Trump executive order is set to set off a wave worth a potential $194 trillion in the markets.
And Wall Street insider Larry Benedict says it could hand investors who missed out on Trump’s first term a second chance. | | Click here to discover this exciting new trading pattern. |
|
Stocks | | How much hype is left in Nvidia's stock? Anyone with an S&P 500 index fund is hoping to get an answer to that weighty question next week. Nvidia has ridden Wall Street's mania around artificial intelligence to become one of the stock market's most massive companies, with a total value topping $3... Read the Full Story |
|
Stocks | | U.S. stocks ticked higher Wednesday after more big companies delivered profit reports that topped analysts’ expectations.The S&P 500 rose 0.4% a day after breaking an eight-day winning streak, its longest of the year. The index is back to within 0.8% of its all-time high set last month.The Dow J... Read the Full Story |
|
|
Markets | |
Stanley Druckenmiller, a renowned investor with a stellar track record, has made headlines with his family office, Duquesne, selling its position in NVIDIA (NASDAQ: NVDA) after accurately predicting the AI boom and NVDA's subsequent surge. Druckenmiller first invested in NVIDIA in the fourth quart... Read the Full Story |
|
Stocks | | U.S. stocks weakened Thursday in the run-up to Wall Street's main event for the week, a speech by Federal Reserve Chair Jerome Powell coming on Friday. The S&P 500 fell 0.9% for its worst day following a two-week rally. The Dow Jones Industrial Average dropped 177 points, or 0.4%, and the Nasda... Read the Full Story |
|
|
Markets | | Japan racked up a 621 billion yen ($4.3 billion) trade deficit in July, as prices of imports surged, according to government data released Wednesday.Japan’s imports grew nearly 17% from a year ago to 10.2 trillion yen ($70.6 billion), while exports grew 10% to 9.6 trillion yen ($66 billion), the Fin... Read the Full Story |
|
Markets | | A gold rush is here. The precious metal hit an all time high this week.The spot price for gold closed Tuesday above $2,514, according to data from FactSet. That's the highest closing price recorded for the commodity to date. Here's what you need to know.What is the price of gold today?The spot price... Read the Full Story |
|
Markets | |
The late July and early August sell-off may have spooked many investors, but it also opened up some very tempting entry opportunities. Already, we’re seeing market-wide recovery rallies reclaim much of the lost gains, but there’s still some edge to be had for investors w... Read the Full Story |
|
Markets | |
Snowflake Inc. (NYSE: SNOW) is a prominent player in the rapidly growing cloud data platform market. It recently released its earnings report for the second quarter of fiscal year 2025. The company continued to demonstrate impressive performance, exceeding Snowflake’s analyst communit... Read the Full Story |
|
Markets | |
Target Corporation (NYSE: TGT) recently released its earnings report for the second quarter of 2024. The company’s latest report exceeded the expectations of its analyst community, prompting a surge in investor confidence and Target’s stock price. The company reported strong fin... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. The company also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts. | View Today's Stock Pick |
|